<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Swk Holdings Corp — News on 6ix</title>
<link>https://6ix.com/company/swk-holdings-corp</link>
<description>Latest news and press releases for Swk Holdings Corp on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 06 Nov 2025 22:10:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/swk-holdings-corp" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835c61878dffbe2df11ae29.webp</url>
<title>Swk Holdings Corp</title>
<link>https://6ix.com/company/swk-holdings-corp</link>
</image>
<item>
<title>SWK Holdings Corporation Announces Financial Results for Third Quarter 2025</title>
<link>https://6ix.com/company/swk-holdings-corp/news/swk-holdings-corporation-announces-financial-221000674</link>
<guid isPermaLink="true">https://6ix.com/company/swk-holdings-corp/news/swk-holdings-corporation-announces-financial-221000674</guid>
<pubDate>Thu, 06 Nov 2025 22:10:00 GMT</pubDate>
<description>Corporate Highlights Third quarter 2025 GAAP net income was $8.8 million, compared with GAAP net income of $3.5 million for the third quarter 2024. Third quarter 2025 income before tax expense was $10.7 million, compared with net income before tax ...</description>
</item>
<item>
<title>SWK Holdings Corporation Announces Financial Results for Second Quarter 2025</title>
<link>https://6ix.com/company/swk-holdings-corp/news/swk-holdings-corporation-announces-financial-211500882</link>
<guid isPermaLink="true">https://6ix.com/company/swk-holdings-corp/news/swk-holdings-corporation-announces-financial-211500882</guid>
<pubDate>Thu, 14 Aug 2025 21:15:00 GMT</pubDate>
<description>Conference Call Scheduled for Friday, August 15, 2025, at 09:00 a.m. CST Corporate Highlights Second quarter 2025 GAAP net income was $3.5 million, compared with GAAP net income of $3.7 million for the second quarter 2024. Second quarter 2025 finance ...</description>
</item>
<item>
<title>SWK Holdings Announces Second Quarter 2025 Earnings Release Date and Conference Call</title>
<link>https://6ix.com/company/swk-holdings-corp/news/swk-holdings-announces-second-quarter-113000533</link>
<guid isPermaLink="true">https://6ix.com/company/swk-holdings-corp/news/swk-holdings-announces-second-quarter-113000533</guid>
<pubDate>Thu, 07 Aug 2025 11:30:00 GMT</pubDate>
<description>DALLAS, TX / ACCESS Newswire / August 7, 2025 /SWK Holdings Corporation (Nasdaq:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced that it will ...</description>
</item>
<item>
<title>Callodine Group Appoints Winston Black as Head of Life Sciences Finance Strategy</title>
<link>https://6ix.com/company/swk-holdings-corp/news/callodine-group-appoints-winston-black-as-head-of-life-sciences-finance-strategy</link>
<guid isPermaLink="true">https://6ix.com/company/swk-holdings-corp/news/callodine-group-appoints-winston-black-as-head-of-life-sciences-finance-strategy</guid>
<pubDate>Thu, 31 Jul 2025 12:30:00 GMT</pubDate>
<description>BOSTON, July 31, 2025--Callodine Group ("Callodine") is pleased to announce the appointment of Winston Black as the Head of Callodine’s newly formed Life Sciences Finance Strategy. In this role, Mr. Black will lead the firm’s efforts in sourcing, underwriting, and managing structured investments across the life sciences sector, with a focus on commercial-stage companies.</description>
</item>
<item>
<title>Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition</title>
<link>https://6ix.com/company/swk-holdings-corp/news/aptar-pharma-bolsters-clinical-trial-capabilities-with-strategic-materials-manufacturing-acquisition</link>
<guid isPermaLink="true">https://6ix.com/company/swk-holdings-corp/news/aptar-pharma-bolsters-clinical-trial-capabilities-with-strategic-materials-manufacturing-acquisition</guid>
<pubDate>Tue, 15 Jul 2025 21:00:00 GMT</pubDate>
<description>CRYSTAL LAKE, Ill., July 15, 2025--Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition</description>
</item>
<item>
<title>SWK Holdings Corporation Announces Financial Results for First Quarter 2025</title>
<link>https://6ix.com/company/swk-holdings-corp/news/swk-holdings-corporation-announces-financial-203000081</link>
<guid isPermaLink="true">https://6ix.com/company/swk-holdings-corp/news/swk-holdings-corporation-announces-financial-203000081</guid>
<pubDate>Thu, 15 May 2025 20:30:00 GMT</pubDate>
<description>Conference Call Scheduled for Friday, May 16, 2025, at 09:00 a.m. CST Corporate Highlights First quarter 2025 GAAP net income was $4.5 million, compared with GAAP net income of $0.5 million for the first quarter 2024. First quarter 2025 finance receivables ...</description>
</item>
<item>
<title>SWK Holdings Announces First Quarter 2025 Earnings Release Date and Conference Call</title>
<link>https://6ix.com/company/swk-holdings-corp/news/swk-holdings-announces-first-quarter-113000745</link>
<guid isPermaLink="true">https://6ix.com/company/swk-holdings-corp/news/swk-holdings-announces-first-quarter-113000745</guid>
<pubDate>Fri, 09 May 2025 11:30:00 GMT</pubDate>
<description>DALLAS, TX / ACCESS Newswire / May 9, 2025 /SWK Holdings Corporation (Nasdaq:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced that it will ...</description>
</item>
<item>
<title>SWK Holdings Announces Closing of Royalty Sale and $4.00 Per Share Special Dividend</title>
<link>https://6ix.com/company/swk-holdings-corp/news/swk-holdings-announces-closing-royalty-201500198</link>
<guid isPermaLink="true">https://6ix.com/company/swk-holdings-corp/news/swk-holdings-announces-closing-royalty-201500198</guid>
<pubDate>Thu, 10 Apr 2025 20:15:00 GMT</pubDate>
<description>DALLAS, TX / ACCESS Newswire / April 10, 2025 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company, today announced the closing of the previously announced royalty sale to SCOF SPV I, ...</description>
</item>
<item>
<title>SWK Holdings Announces Monetization of Royalty Portfolio</title>
<link>https://6ix.com/company/swk-holdings-corp/news/swk-holdings-announces-monetization-royalty-012000654</link>
<guid isPermaLink="true">https://6ix.com/company/swk-holdings-corp/news/swk-holdings-announces-monetization-royalty-012000654</guid>
<pubDate>Thu, 20 Mar 2025 01:20:00 GMT</pubDate>
<description>DALLAS, TX / ACCESS Newswire / March 19, 2025 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced the monetization ...</description>
</item>
<item>
<title>SWK Holdings Corporation Announces Financial Results for Fourth Quarter 2024</title>
<link>https://6ix.com/company/swk-holdings-corp/news/swk-holdings-corporation-announces-financial-011000711</link>
<guid isPermaLink="true">https://6ix.com/company/swk-holdings-corp/news/swk-holdings-corporation-announces-financial-011000711</guid>
<pubDate>Thu, 20 Mar 2025 01:10:00 GMT</pubDate>
<description>Conference Call Scheduled for Thursday, March 20, 2025, at 09:00 a.m. CST Corporate Highlights Fourth quarter 2024 GAAP net income was $5.9 million, compared with GAAP net income of $2.8 million for the fourth quarter 2023. Fourth quarter 2024 finance ...</description>
</item>
<item>
<title>SWK Holdings Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call</title>
<link>https://6ix.com/company/swk-holdings-corp/news/swk-holdings-announces-fourth-quarter-113000280</link>
<guid isPermaLink="true">https://6ix.com/company/swk-holdings-corp/news/swk-holdings-announces-fourth-quarter-113000280</guid>
<pubDate>Thu, 13 Mar 2025 11:30:00 GMT</pubDate>
<description>DALLAS, TX / ACCESS Newswire / March 13, 2025 /SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced that it will ...</description>
</item>
<item>
<title>Enteris BioPharma to Exhibit at CPhI North America 2022</title>
<link>https://6ix.com/company/swk-holdings-corp/news/enteris-biopharma-to-exhibit-at-cphi-north-america-2022</link>
<guid isPermaLink="true">https://6ix.com/company/swk-holdings-corp/news/enteris-biopharma-to-exhibit-at-cphi-north-america-2022</guid>
<pubDate>Wed, 04 May 2022 04:00:00 GMT</pubDate>
<description>BOONTON, N.J., May 4, 2022 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary</description>
</item>
<item>
<title>Enteris BioPharma Announces Acceptance of Two Abstracts for Presentation at ENDO 2022 Annual Conference</title>
<link>https://6ix.com/company/swk-holdings-corp/news/enteris-biopharma-announces-acceptance-of-two-abstracts-for-presentation-at-endo-2022-annual-conference</link>
<guid isPermaLink="true">https://6ix.com/company/swk-holdings-corp/news/enteris-biopharma-announces-acceptance-of-two-abstracts-for-presentation-at-endo-2022-annual-conference</guid>
<pubDate>Tue, 12 Apr 2022 04:00:00 GMT</pubDate>
<description>BOONTON, N.J., April 12, 2022 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary</description>
</item>
<item>
<title>SWK Holdings Announces Reconstitution of Board of Directors with New Appointments</title>
<link>https://6ix.com/company/swk-holdings-corp/news/swk-holdings-announces-reconstitution-of-board-of-directors-with-new-appointments</link>
<guid isPermaLink="true">https://6ix.com/company/swk-holdings-corp/news/swk-holdings-announces-reconstitution-of-board-of-directors-with-new-appointments</guid>
<pubDate>Wed, 16 Feb 2022 05:00:00 GMT</pubDate>
<description>DALLAS, Feb. 16, 2022 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and</description>
</item>
<item>
<title>SWK Holdings Provides Portfolio Update Highlighting Recent Achievements</title>
<link>https://6ix.com/company/swk-holdings-corp/news/swk-holdings-provides-portfolio-update-highlighting-recent-achievements</link>
<guid isPermaLink="true">https://6ix.com/company/swk-holdings-corp/news/swk-holdings-provides-portfolio-update-highlighting-recent-achievements</guid>
<pubDate>Wed, 09 Feb 2022 05:00:00 GMT</pubDate>
<description>Fourth Quarter 2021 Financial Results to be Announced in March DALLAS, Feb. 9, 2022 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the</description>
</item>
<item>
<title>Enteris BioPharma Launches Enhanced Website Showcasing Full Suite of Bench to Market™ Services</title>
<link>https://6ix.com/company/swk-holdings-corp/news/enteris-biopharma-launches-enhanced-website-showcasing-full-suite-of-bench-to-markettm-services</link>
<guid isPermaLink="true">https://6ix.com/company/swk-holdings-corp/news/enteris-biopharma-launches-enhanced-website-showcasing-full-suite-of-bench-to-markettm-services</guid>
<pubDate>Mon, 10 Jan 2022 05:00:00 GMT</pubDate>
<description>BOONTON, N.J., Jan. 10, 2022 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary</description>
</item>
<item>
<title>Special Committee Concludes Review of Non-Binding Proposal from Carlson Capital</title>
<link>https://6ix.com/company/swk-holdings-corp/news/special-committee-concludes-review-of-non-binding-proposal-from-carlson-capital</link>
<guid isPermaLink="true">https://6ix.com/company/swk-holdings-corp/news/special-committee-concludes-review-of-non-binding-proposal-from-carlson-capital</guid>
<pubDate>Wed, 05 Jan 2022 05:00:00 GMT</pubDate>
<description>DALLAS, Jan. 5, 2022 /PRNewswire/ --SWK Holdings Corporation (Nasdaq: SWKH) (the "Company" or "SWK") today announced that the special committee of the</description>
</item>
<item>
<title>SWK Holdings Provides $10M USD to MolecuLight to Support Global Commercial Expansion</title>
<link>https://6ix.com/company/swk-holdings-corp/news/swk-holdings-provides-dollar10m-usd-to-moleculight-to-support-global-commercial-expansion</link>
<guid isPermaLink="true">https://6ix.com/company/swk-holdings-corp/news/swk-holdings-provides-dollar10m-usd-to-moleculight-to-support-global-commercial-expansion</guid>
<pubDate>Tue, 04 Jan 2022 05:00:00 GMT</pubDate>
<description>DALLAS and TORONTO, Jan. 4, 2022 /PRNewswire/ - MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds</description>
</item>
<item>
<title>SWK Holdings' Subsidiary, Enteris BioPharma, Receives $5 Million Milestone Payment from Cara Therapeutics</title>
<link>https://6ix.com/company/swk-holdings-corp/news/swk-holdings-subsidiary-enteris-biopharma-receives-dollar5-million-milestone-payment-from-cara-therapeutics-1</link>
<guid isPermaLink="true">https://6ix.com/company/swk-holdings-corp/news/swk-holdings-subsidiary-enteris-biopharma-receives-dollar5-million-milestone-payment-from-cara-therapeutics-1</guid>
<pubDate>Thu, 09 Dec 2021 05:00:00 GMT</pubDate>
<description>Fourth milestone payment triggered by successful completion of process technology transfer related to the development of Oral KORSUVA™ DALLAS, Dec. 9, 2021</description>
</item>
<item>
<title>SWK Holdings Confirms Receipt of Non-Binding Proposal from Carlson Capital L.P.</title>
<link>https://6ix.com/company/swk-holdings-corp/news/swk-holdings-confirms-receipt-of-non-binding-proposal-from-carlson-capital-lp</link>
<guid isPermaLink="true">https://6ix.com/company/swk-holdings-corp/news/swk-holdings-confirms-receipt-of-non-binding-proposal-from-carlson-capital-lp</guid>
<pubDate>Wed, 24 Nov 2021 05:00:00 GMT</pubDate>
<description>Announces Formation of Special Committee DALLAS, Nov. 24, 2021 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) (the "Company" or "SWK") confirmed that</description>
</item>
</channel>
</rss>